Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions		Jun. 30, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents		$ 632	$ 400
Restricted cash and cash equivalents (Note 16)		483	501
Accounts receivable, net (Note 4)		151	137
Inventory, net (Note 6)		280	375
Derivative instruments (Notes 3 and 12)		27	89
Other current assets	[1]	380	52
Total current assets		1,953	1,554
Property, plant and equipment, net (Note 8)		3,250	3,839
Nuclear decommissioning trust funds (Notes 7 and 12)		1,659	1,575
Derivative instruments (Notes 3 and 12)		13	6
Other noncurrent assets		207	147
Total Assets		7,082	7,121
Liabilities and Equity
Long-term debt, due within one year (Notes 11 and 12)		9	9
Accrued interest		31	32
Accounts payable and other accrued liabilities		212	344
Derivative instruments (Notes 3 and 12)		63	32
Other current liabilities		118	69
Total current liabilities		433	486
Long-term debt (Notes 11 and 12)		2,617	2,811
Derivative instruments (Notes 3 and 12)		1	11
Postretirement benefit obligations (Note 13)		364	368
Asset retirement obligations and accrued environmental costs (Note 9)		473	469
Deferred income taxes (Note 5)		495	407
Other noncurrent liabilities		127	35
Total Liabilities		4,510	4,587
Commitments and Contingencies (Note 10)
Stockholders’ Equity
Common stock ($0.001 par value 350,000,000 shares authorized)	[2],[3]	0	0
Additional paid-in capital		2,092	2,346
Accumulated retained earnings (deficit)		448	134
Accumulated other comprehensive income (loss)		(29)	(23)
Total Stockholders’ Equity		2,511	2,457
Noncontrolling interests		61	77
Total Equity		2,572	2,534
Total Liabilities and Equity		$ 7,082	$ 7,121

[1] Includes $300 million of proceeds from the Cumulus Data Campus Sale held in escrow.

[2] As of June 30, 2024 (Successor): 53,259,981 shares issued, 53,254,954 shares outstanding, and 5,027 shares held as treasury stock.

[3] As of December 31, 2023 (Successor): 59,028,843 shares issued and outstanding.